Antimicrobial
Resistance (AMR)

Why It Matters to All of Us ?

What is Antimicrobial Resistance?

Antimicrobials—like antibiotics—have saved millions of lives. They help us recover from infections that were once deadly. But today, these life-saving medicines are slowly losing their power.

Antimicrobial Resistance (AMR) happens when bacteria, viruses, fungi, or parasites no longer respond to medicines that once worked against them. This means infections become harder to treat, take longer to heal, and can spread more easily to others.¹²

AMR develops naturally over time, but it is speeding up because of how we use—and misuse—antimicrobials. Taking antibiotics when they aren’t needed, not completing prescribed courses, or using them without medical advice gives germs the chance to adapt and fight back.¹

Why Is Tackling Antimicrobial Resistance (AMR) So Challenging?

Stopping Antimicrobial Resistance (AMR) isn’t easy, and there are real-world reasons behind it:

Antibiotics are often overused or misused

Many people still take antibiotics for viral infections like colds or flu, even though these medicines don’t work against viruses.¹³

We don’t always see resistance coming

In many parts of the world, limited testing and weak surveillance systems make it hard to detect resistant infections early.¹

Few new antibiotics are being developed

While resistance is increasing, the number of new antibiotics entering the market remains very small. This leaves doctors with fewer treatment options.⁴

Infections spread easily in healthcare settings

Overcrowding, poor hygiene, and limited infection-control measures allow resistant germs to pass from one person to another.¹

AMR knows no borders

Resistant infections can travel quickly across countries through people, food, and the environment, making AMR a global challenge—not a local one.²

How Does AMR Affect Human Life?

The impact of Antimicrobial Resistance (AMR) goes far beyond hospitals and laboratories—it affects everyday life:

Lives are being lost

Drug-resistant infections were directly responsible for about 1.27 million deaths worldwide in 2019, and played a role in nearly 5 million deaths overall.²

Routine treatments become risky

Common procedures like surgeries, chemotherapy, and care for newborns depend on effective antibiotics. Without them, even simple treatments become dangerous.¹⁴

Illness lasts longer and costs more

Resistant infections often mean longer hospital stays, stronger medicines, and higher medical costs for patients and families.¹

The most vulnerable suffer the most

Children, older adults, and people with weakened immunity face the highest risk, especially in settings with limited access to quality healthcare.⁵

What Can We Do to Prevent AMR?

The good news is that everyone has a role to play in slowing down AMR:

Use antimicrobials wisely

  • Take antibiotics only when prescribed by a qualified healthcare professional.
  • Never pressure doctors for antibiotics if they say they aren’t needed.¹

Protect yourself from infections

  • Wash hands regularly and maintain good hygiene.
  • Stay up to date with recommended vaccinations to prevent infections in the first place.¹

Complete the full course

  • Always finish the full course of prescribed antibiotics, even if you feel better sooner.¹

Support better healthcare practices

Encourage infection-prevention measures in hospitals and clinics.

Support antimicrobial stewardship programs that promote responsible prescribing.³

Think beyond human health

Antimicrobial Resistance (AMR) must be addressed using a One Health approach, recognizing the close connection between human health, animal health, and the environment.¹

References

  1. World Health Organization. Antimicrobial resistance – Fact sheet. WHO; 2023.
  2. Murray CJL et al. Global burden of bacterial antimicrobial resistance in 2019. The Lancet. 2022;399:629–655.
  3. World Health Organization. Global Action Plan on Antimicrobial Resistance. WHO; 2015.
  4. World Health Organization. Antibacterial agents in clinical and preclinical development. WHO; 2022.
  5. World Bank. Drug-Resistant Infections: A Threat to Our Economic Future. World Bank; 2017.
  6. World Health Organization. Infection prevention and control programmes: WHO guidelines. WHO; 2016.